Applied DNA Sciences, Inc. (APDN) financial statements (2022 and earlier)
Company profile
| Business Address |
50 HEALTH SCIENCES DRIVE STONY BROOK, NY 11790 |
| State of Incorp. | DE |
| Fiscal Year End | September 30 |
| SIC | 738 - Miscellaneous Business Services (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in thousands)
| 12/31/2021 TTM | 9/30/2021 | 9/30/2020 | 9/30/2019 | 9/30/2018 | |||
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current Assets | |||||||
| Cash, cash equivalents, and short-term investments | 2,748 | 7,787 | 559 | 1,660 | |||
| Cash and cash equivalents | 2,748 | 7,787 | 559 | 1,660 | |||
| Receivables | 3,857 | 194 | 840 | 1,486 | |||
| Inventory, net of allowances, customer advances and progress billings | 1,301 | 497 | 143 | 221 | |||
| Inventory | 1,301 | 497 | 143 | 221 | |||
| Other undisclosed current assets | 593 | 599 | 605 | 635 | |||
| Total current assets: | 8,499 | 9,078 | 2,146 | 4,002 | |||
| Noncurrent Assets | |||||||
| Property, plant and equipment | 2,808 | 1,278 | 226 | 420 | |||
| Intangible assets, net (including goodwill) | 891 | 1,020 | 1,150 | ||||
| Goodwill | 285 | 285 | 285 | ||||
| Intangible assets, net (excluding goodwill) | 605 | 735 | 864 | ||||
| Deposits noncurrent assets | 95 | 95 | 62 | 62 | |||
| Deferred costs | 110 | ||||||
| Total noncurrent assets: | 2,903 | 2,263 | 1,418 | 1,632 | |||
| TOTAL ASSETS: | 11,402 | 11,341 | 3,565 | 5,634 | |||
| LIABILITIES AND EQUITY | |||||||
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts payable and accrued liabilities | 2,521 | 1,926 | 1,617 | 965 | |||
| Accounts payable | 1,761 | 1,250 | 1,152 | 501 | |||
| Accrued liabilities | 364 | 151 | 131 | 63 | |||
| Employee-related liabilities | 397 | 526 | 319 | 401 | |||
| Taxes payable | 15 | ||||||
| Deferred revenue | 458 | 511 | 629 | ✕ | |||
| Debt | 1,828 | ||||||
| Other undisclosed current liabilities | 1,857 | ||||||
| Total current liabilities: | 2,979 | 4,266 | 2,246 | 2,822 | |||
| Noncurrent Liabilities | |||||||
| Long-term debt and lease obligation | 517 | 1,442 | 1,587 | ||||
| Long-term debt, excluding current maturities | 517 | 1,442 | 1,587 | ||||
| Liabilities, other than long-term debt | 31 | 848 | 622 | 471 | |||
| Accounts payable and accrued liabilities | 31 | 848 | 622 | 471 | |||
| Other undisclosed noncurrent liabilities | 103 | ||||||
| Total noncurrent liabilities: | 31 | 1,366 | 2,167 | 2,057 | |||
| Total liabilities: | 3,010 | 5,632 | 4,413 | 4,879 | |||
| Stockholders' equity | |||||||
| Stockholders' equity attributable to parent | 8,392 | 5,718 | (841) | 755 | |||
| Common stock | 7 | 5 | 1 | 30 | |||
| Additional paid in capital | 297,228 | 275,549 | 255,963 | 249,090 | |||
| Accumulated deficit | (288,844) | (269,836) | (256,806) | (248,366) | |||
| Stockholders' equity attributable to noncontrolling interest | 0 | (9) | (7) | ||||
| Total stockholders' equity: | 8,392 | 5,710 | (848) | 755 | |||
| TOTAL LIABILITIES AND EQUITY: | 11,402 | 11,341 | 3,565 | 5,634 | |||
Income statement (P&L) ($ in thousands)
| 12/31/2021 TTM | 9/30/2021 | 9/30/2020 | 9/30/2019 | 9/30/2018 | ||
|---|---|---|---|---|---|---|
| Revenues | 4,257 | 1,931 | 5,389 | 3,903 | ||
| Cost of revenue | (3,057) | (721) | (878) | (1,207) | ||
| Cost of goods and services sold | (878) | |||||
| Other undisclosed gross profit | 2,299 | |||||
| Gross profit: | 9,488 | 1,211 | 4,511 | 2,697 | ||
| Operating expenses | (14,837) | (13,746) | (13,636) | (14,343) | ||
| Other undisclosed operating loss | (8,199) | |||||
| Operating loss: | (13,548) | (12,535) | (9,124) | (11,646) | ||
| Nonoperating expense (Other Nonoperating expense) | (192) | (378) | (43) | (37) | ||
| Interest and debt expense | (26) | (1,260) | (1) | |||
| Loss from continuing operations before equity method investments, income taxes: | (13,740) | (12,939) | (10,428) | (11,685) | ||
| Other undisclosed income (loss) from continuing operations before income taxes | 4 | (90) | 1,811 | (8) | ||
| Loss from continuing operations before income taxes: | (13,736) | (13,029) | (8,617) | (11,693) | ||
| Income tax expense (benefit) | 3,505 | (15) | (3,505) | |||
| Other undisclosed income from continuing operations | 2,862 | |||||
| Loss before gain (loss) on sale of properties: | (10,874) | (9,524) | (8,632) | (15,198) | ||
| Other undisclosed net loss | (2,862) | (3,505) | ||||
| Net loss: | (13,736) | (13,029) | (8,632) | (15,198) | ||
| Net income (loss) attributable to noncontrolling interest | (8) | 2 | 9 | |||
| Other undisclosed net income attributable to parent | 3,505 | |||||
| Net loss attributable to parent: | (13,744) | (13,027) | (8,623) | (11,693) | ||
| Other undisclosed net loss available to common stockholders, basic | (3) | (310) | ||||
| Net loss available to common stockholders, diluted: | (13,744) | (13,030) | (8,933) | (11,693) | ||
Comprehensive Income ($ in thousands)
| 12/31/2021 TTM | 9/30/2021 | 9/30/2020 | 9/30/2019 | 9/30/2018 | ||
|---|---|---|---|---|---|---|
| Net loss: | (13,736) | (13,029) | (8,632) | (15,198) | ||
| Comprehensive loss: | (13,736) | (13,029) | (8,632) | (15,198) | ||
| Comprehensive income (loss), net of tax, attributable to noncontrolling interest | (8) | 2 | 9 | |||
| Comprehensive loss, net of tax, attributable to parent: | (13,744) | (13,027) | (8,623) | (15,198) | ||
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.